OS Therapies Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: OSTX · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1795091
| Field | Detail |
|---|---|
| Company | Os Therapies Inc (OSTX) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, 8-k
TL;DR
OS Therapies filed an 8-K for a material agreement and equity sales on 6/26.
AI Summary
On June 26, 2025, OS Therapies Inc. entered into a material definitive agreement and reported unregistered sales of equity securities. The company, incorporated in Delaware with its principal executive offices in Grasonville, Maryland, filed this 8-K report on June 27, 2025.
Why It Matters
This filing indicates significant corporate actions, including a new material agreement and the issuance of equity, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves a material definitive agreement and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- OS Therapies Inc. (company) — Registrant
- June 26, 2025 (date) — Date of earliest event reported
- June 27, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Grasonville, Maryland (location) — Principal Executive Offices
- 21638 (zip_code) — Zip code of Principal Executive Offices
- 410-297-7793 (phone_number) — Registrant's telephone number
FAQ
What type of material definitive agreement did OS Therapies Inc. enter into?
The filing states that OS Therapies Inc. entered into a 'Material Definitive Agreement' but does not specify the nature of the agreement in the provided text.
What was the date of the earliest event reported in the 8-K filing?
The earliest event reported in the 8-K filing occurred on June 26, 2025.
Where are the principal executive offices of OS Therapies Inc. located?
The principal executive offices of OS Therapies Inc. are located at 115 Pullman Crossing Road, Suite 103, Grasonville, Maryland, 21638.
What is the SEC file number for OS Therapies Inc.?
The SEC file number for OS Therapies Inc. is 001-42195.
What are the two main items reported in this 8-K filing?
This 8-K filing reports on the 'Entry into a Material Definitive Agreement' and 'Unregistered Sales of Equity Securities'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding OS Therapies Inc (OSTX).